Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Oncothyreon
Oncothyreon
Oncothyreon Files Investigational New Drug Application for ONT-10
Yahoo
Tue, 12/20/11 - 11:04 am
Oncothyreon
ONT-10
cancer
vaccines
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Oncothyreon: $31 For Shares? Don't Believe The Hype
Seeking Alpha
Mon, 11/28/11 - 11:40 am
Oncothyreon
Using Options In Speculative Biotech Investing
Seeking Alpha
Mon, 10/10/11 - 11:26 am
Antares Pharma
Aeterna Zentaris
options
Dendreon
BioSante
Keryx
Oncothyreon
6 Deeply Undervalued Biotech Companies
Seeking Alpha
Wed, 09/14/11 - 11:03 am
Amgen
Biogen Idec
Bristol-Myers Squibb
Dendreon
Gilead
GSK
Oncothyreon
JNJ
Novartis
Sanofi
UBS
Vanda
6 Companies That Could Revolutionize Medicine -- And Portfolios
Seeking Alpha
Fri, 08/19/11 - 09:13 am
Opexa
RXi Pharmaceuticals
Oncothyreon
Celldex
Advanced Cell Technologies
Keryx
Oncothyreon: Analyzing Trial Data and Concluding Likely Success
Seeking Alpha
Fri, 07/29/11 - 08:26 am
Oncothyreon
Stimuvax
vaccines
cancer
Oncothyreon: Possible Pharma Blockbuster
Seeking Alpha
Wed, 07/20/11 - 12:53 pm
Oncothyreon
Stimuvax
non-small cell lung cancer
Immunocellular Therapeutics: An Interesting Biotech
Seeking Alpha
Tue, 07/19/11 - 12:12 pm
ImmunoCellular Therapeutics
cancer
Bristol-Myers Squibb
Dendreon
Oncothyreon
Oncothyreon: Deep Dive Into Stimuvax
Seeking Alpha
Mon, 07/11/11 - 10:14 am
Stimuvax
Oncothyreon
lung cancer
Ideas in the Biotech Sector
Seeking Alpha
Sat, 07/9/11 - 10:55 am
Amag Pharmaceuticals
Dendreon
Oncothyreon
Should Biotech Investors Go Where Institutions Won't?
Investopedia
Thu, 07/7/11 - 12:04 pm
investors
biotech
Aeterna Zentaris
YM BioSciences
Ziopharm
Oncothyreon
Seattle Genetics
Exelixis
MannKind
MELA Sciences
Neoprobe
Zalicus
10 Biotech Trades for Second Half of 2011
TheStreet.com
Wed, 07/6/11 - 08:51 am
Sangamo BioSciences
BioSante
Seattle Genetics
YM BioSciences
Exelixis
Transcept
Oncothyreon
Gilead Sciences
Medivation
Neoprobe
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Seeking Alpha
Mon, 07/4/11 - 09:20 am
Dendreon
prostate cancer
cancer immunotherapy
Cel-Sci
Cell Therapeutics
ImmunoCellular
Keryx
Teva Pharmaceuticals
Oncothyreon
It May Be Time to Throttle Back on Oncothyreon
Seeking Alpha
Mon, 06/27/11 - 09:27 am
Oncothyreon
Dendreon
ImmunoCellular
Merck KGaA
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sun, 06/26/11 - 12:03 pm
Dendreon
prostate cancer
DN24-02
Neuvenge
Provenge
Oncothyreon
Stimuvax
colorectal cancer
breast cancer
Keryx
Analyst expects positive cancer drug trial results from Oncothyreon later this year
Yahoo/AP
Fri, 06/24/11 - 09:24 am
Oncothyreon
Stimuvax
lung cancer
Cancer Vaccines and Oncothyreon: Flying Higher as Market Sinks
Seeking Alpha
Thu, 06/16/11 - 11:31 am
Oncothyreon
vaccines
cancer
Biovest International
Antigenics
Dendreon
CytRx
ImmunoCellular
Keryx
Oncothyreon: Could Be a Big Player in Cancer Treatment
Seeking Alpha
Thu, 05/26/11 - 12:15 pm
Oncothyreon
cancer
11 Potential Biotech Buy Out Targets
Seeking Alpha
Wed, 05/18/11 - 11:50 am
M&A
Alexion
Celgene
Biogen Idec
Celldex
Geron
Illumina
Micromet
Mylan
Vical
Oncothyreon
Pharmasset
Pages
« first
‹ previous
1
2
3
4
next ›
last »